Evidence map›Paper›PMID 28125631›Full record

ArticlePloS one2017

Comprehensive Annotation of Mature Peptides and Genotypes for Zika Virus.

Guangyu Sun, Christopher N Larsen, Nicole Baumgarth, Edward B Klem, Richard H Scheuermann

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Potential biomarkers inBioinformation · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guangyu SunVecna Technologies, Inc., Greenbelt, Maryland, United States of America.
Christopher N LarsenVecna Technologies, Inc., Greenbelt, Maryland, United States of America.ORCID http://orcid.org/0000-0002-1051-5767
Nicole BaumgarthCenter for Comparative Medicine and the Department of Pathology, Microbiology & Immunology, University of California, Davis, Davis, California, United States of America.
Edward B KlemNorthrop Grumman Health Solutions, Rockville, Maryland, United States of America.
Richard H ScheuermannJ. Craig Venter Institute, La Jolla, California, United States of America.

Funding

Advanced Infection Control methods for Antimicrobial Drug Resistance and PathogenR43NR012128 · NINR · VECNA TECHNOLOGIES, INC. · PI LARSEN, CHRISTOPHER N. · 2010 to 2010
$163k
NIAID NIH HHS HHSN272201400028CNINR NIH HHS R43 NR012128
6 · The paper itself

Abstract

The rapid spread of Zika virus (ZIKV) has caused much concern in the global health community, due in part to a link to fetal microcephaly and other neurological illnesses. While an increasing amount of ZIKV genomic sequence data is being generated, an understanding of the virus molecular biology is still greatly lacking. A significant step towards establishing ZIKV proteomics would be the compilation of all proteins produced by the virus, and the resultant virus genotypes. Here we report for the first time such data, using new computational methods for the annotation of mature peptide proteins, genotypes, and recombination events for all ZIKV genomes. The data is made publicly available through the Virus Pathogen Resource at www.viprbrc.org.

Indexed as

Genes, ViralGenotypeHumansPeptidesPublic HealthViral ProteinsZika VirusZika Virus InfectionPeptidesViral Proteins

Identifiers

PMID28125631
PMCPMC5268401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.